Rigetti Computing, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Rigetti Computing, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $13.10M | Mar 27, 2023 |
| FY2022 | Dec 31, 2021 | $8.20M | Mar 27, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.06M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $5.70M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $9.21M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $10.23M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $6.57M | Mar 27, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($216.21M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($200.99M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($75.11M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($71.52M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($38.24M) | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | ($14.7K) | Feb 23, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($84.66M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($68.51M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($72.30M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($109.08M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($34.13M) | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | ($14.7K) | Feb 23, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.35M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $49.75M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $52.77M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $59.95M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $26.93M | Mar 27, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($58.54M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($50.63M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($50.58M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($62.69M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($29.04M) | Mar 27, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.68M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $11.10M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $9.06M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $22.74M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $7.01M | Mar 27, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $666.57M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $284.79M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $159.91M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $203.44M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $46.43M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $43.3K | Feb 23, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.38M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $158.20M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $50.33M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $53.22M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $36.43M | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $33.0K | Feb 23, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $546.20M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $126.59M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $109.59M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $150.22M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | ($71.53M) | Mar 14, 2024 |
| FY2022 | Jan 31, 2021 | ($35.43M) | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | $10.3K | Feb 23, 2022 |
| FY2021 | Dec 21, 2020 | $0 | Feb 23, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 27, 2023 |
| FY2023 | Dec 31, 2021 | $5.38M | Mar 14, 2024 |
| FY2022 | Jan 31, 2021 | $5.38M | Mar 27, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($770.96M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($554.75M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($353.76M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($278.65M) | Mar 14, 2024 |
| FY2022 | Jan 1, 2022 | $0 | Mar 27, 2023 |
| FY2022 | Dec 31, 2021 | ($207.13M) | Mar 27, 2023 |
| FY2021 | Dec 31, 2020 | ($14.7K) | Feb 23, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.85M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $67.67M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $21.39M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $57.89M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $11.73M | Mar 27, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 27, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 27, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 331.28M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 283.55M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 147.07M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 125.26M | Mar 14, 2024 |
| FY2023 | Sep 14, 2022 | 1.00M | Mar 14, 2024 |
| FY2023 | Aug 11, 2022 | 23.65M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 18.22M | Mar 27, 2023 |